Screener
Omada Health OMDA Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$87.8MBeat by $7.8M
EPS$0.15Beat by $0.09
Revenue estimate$80.0M
EPS estimate$0.06
“Our outstanding second quarter reflects the strength of our strategy, the momentum we've built across the business, and the exceptional team driving Omada forward. Reflecting continued demand for our integrated between-visit care platform, total members increased 45% year over year as we expanded our commercial channels, deepened relationships with our leading PBM channels, and introduced our cholesterol management program with one of the nation's largest retailers. The opportunity ahead is significant, and we'll remain focused on disciplined execution as we look to broaden our capabilities, deepen customer relationships and improve the health of even more members.”
Next report
Nov 5, 2026 (in 3 months)Revenue estimate$84.4M
EPS estimate$0.07
Financials
Q2 2026Valuation & ratios
Segments
Versus estimates
Revenue
Q2 2026$87.8MBeat by $7.8M
Q1 2026$78.0MBeat by $4.0MQ4 2025$75.8MBeat by $5.6MQ3 2025$68.0MMiss by $1.0MQ2 2025$61.4MBeat by $5.9MDiluted EPS
FAQ
- When did Omada Health report Q2 2026 earnings?
- Omada Health (OMDA) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Omada Health's Q2 2026 revenue and EPS?
- Omada Health reported revenue of $87.8M and eps of $0.15 for Q2 2026.
- Did Omada Health beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $80.0M by $7.8M. EPS beat the consensus estimate of $0.06 by $0.09.
- How did Omada Health's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.1% from $61.4M a year earlier.
- Where can I find Omada Health's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-054266) and the 10-Q periodic report (0001628280-26-054840) directly on SEC EDGAR. The filing index links above go to sec.gov.
